- Share Prices
Crism Therapeutics Corporation (CRTX)
8.75p+0.00 (+0.00%)11 Dec 2025, 17:15
Crism Therapeutics Corporation Market & Company News
| 10.12.2025 16:16 | AMRQ, CRTX, DOTD | TRADING UPDATES: Netcall acquires Jadu for up to GBP19 million | Alliance |
| 10.12.2025 07:25 | CRTX | Retail Offer | RNS |
| 10.12.2025 07:00 | CRTX | Placing of £1,000,000 | RNS |
| 27.11.2025 07:00 | CRTX | Holding(s) in Company | RNS |
| 30.10.2025 07:00 | CRTX | US Orphan Drug Designation Application | RNS |
| 14.10.2025 16:50 | CRTX | CRISM reports "significant" preclinical data for prostate cancer drug | Alliance |
| 14.10.2025 07:00 | CRTX | Positive Preclinical Data in Prostate Cancer | RNS |
| 15.09.2025 21:41 | CRTX, EOG, INV | EARNINGS: CRISM loss widens as "actively" prepares for phase 2 trial | Alliance |
| 15.09.2025 07:00 | CRTX | Half Year Report | RNS |
| 12.09.2025 07:00 | CRTX | Notice of Interim Results and IMC Presentation | RNS |
| 01.09.2025 07:00 | CRTX | Approval for phase 2 clinical trial | RNS |
| 26.08.2025 16:03 | CRTX | Result of AGM | RNS |
| 26.08.2025 13:56 | CRTX | IN BRIEF: CRISM confident in ChemoSeed as targets trial approval | Alliance |
| 26.08.2025 07:00 | CRTX | AGM Statement | RNS |
| 19.08.2025 14:58 | UJO, PCA, LIV | UK shareholder meetings calendar - next 7 days | Alliance |
| 12.08.2025 07:00 | CRTX | GMP Manufacture of ChemoSeed | RNS |
| 04.08.2025 17:45 | CRTX | Notice of AGM and EMI Option Plan | RNS |
| 10.07.2025 15:04 | CRTX | Holding(s) in Company | RNS |
| 03.07.2025 07:00 | CRTX | Result of Retail Offer and Additional Placing | RNS |
| 01.07.2025 16:41 | CRTX | Update presentation on the IMC platform | Reach |
| 01.07.2025 07:00 | CRTX | Submission of CTA Application | RNS |
| 30.06.2025 11:03 | CRTX, MDZ | AIM WINNERS & LOSERS: MediaZest swings to profit, remains optimistic | Alliance |
| 30.06.2025 07:01 | CRTX | Retail Offer | RNS |
| 30.06.2025 07:00 | CRTX | Placing | RNS |
| 13.06.2025 09:43 | CRTX | CRISM Therapeutics hails progress in glioblastoma as loss widens | Alliance |
| 13.06.2025 07:00 | CRTX | Final Results for the year ended 31 December 2024 | RNS |
| 09.06.2025 07:00 | CRTX | Best Paper Award | Reach |
| 03.06.2025 12:24 | CRTX | CRISM Therapeutics sets up advisory board ahead of ChemoSeed trial | Alliance |
| 03.06.2025 07:00 | CRTX | Establishment of Scientific Advisory Board | RNS |
| 07.04.2025 11:46 | CRTX | Director Dealing | RNS |
| 31.03.2025 07:00 | CRTX | Clinical Trial Update | RNS |
| 27.03.2025 07:00 | CRTX | Innovate UK Grant Award | RNS |
| 20.12.2024 07:00 | CRTX | Appointment of Specialist Clinical CRO | RNS |
| 19.12.2024 08:32 | CRTX | IN BRIEF: CRISM Therapeutics gets European patent for tumour therapy | Alliance |
| 18.12.2024 07:00 | CRTX | European Patent Grant | RNS |
| 19.09.2024 07:00 | CRTX | Interim Results | RNS |
| 12.09.2024 13:55 | THG, SFOR, PMP | UK earnings, trading statements calendar - next 7 days | Alliance |
| 09.09.2024 07:00 | CRTX | Notice of Interim Results & IMC Presentation | RNS |
| 03.09.2024 07:00 | CRTX | Delivery Method Validated in Peer Reviewed Journal | Reach |
| 02.09.2024 07:00 | CRTX | Innovation Passport Award | RNS |
